MDM2 as a Rational Target for Intervention in CDK4/6 Inhibitor Resistant, Hormone Receptor Positive Breast Cancer

Overview of attention for article published in Frontiers in oncology, November 2021

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age and source (56th percentile)

Mentioned by

twitter: 2 X users

Readers on

mendeley: 15 Mendeley

Summary X

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 6,960 followers.

RT @FrontOncology: New research: MDM2 as a Rational Target for Intervention in CDK4/6 Inhibitor Resistant, Hormone Receptor Positive Breast…

04 Nov 2021

Reply Repost Favourite

New research: MDM2 as a Rational Target for Intervention in CDK4/6 Inhibitor Resistant, Hormone Receptor Positive Breast Cancer: With the adoption of inhibitors of cyclin dependent kinases 4 and 6 (CDK4/6i) in combination with endocrine therapy… https://t.

03 Nov 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.